Global Human iPSCs Market Insights, Forecast to 2029
This report presents an overview of global market for Human iPSCs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Human iPSCs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human iPSCs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human iPSCs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Human iPSCs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Human iPSCs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology and ReproCELL, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Human iPSCs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human iPSCs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human iPSCs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Human iPSCs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human iPSCs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human iPSCs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Human iPSCs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Human iPSCs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology and ReproCELL, etc.
By Company
- Fujifilm Holding Corporation (CDI)
- Ncardia
- Sumitomo Dainippon Pharma
- Astellas Pharma Inc
- Fate Therapeutics, Inc
- Pluricell Biotech
- Cell Inspire Biotechnology
- ReproCELL
- Skin
- Blood Cells
- Academic Research
- Drug Development and Discovery
- Toxicity Screening
- Regenerative Medicine
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Human iPSCs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human iPSCs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human iPSCs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human iPSCs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Skin
1.2.3 Blood Cells
1.3 Market by Application
1.3.1 Global Human iPSCs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Human iPSCs Market Perspective (2018-2029)
2.2 Global Human iPSCs Growth Trends by Region
2.2.1 Human iPSCs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human iPSCs Historic Market Size by Region (2018-2023)
2.2.3 Human iPSCs Forecasted Market Size by Region (2024-2029)
2.3 Human iPSCs Market Dynamics
2.3.1 Human iPSCs Industry Trends
2.3.2 Human iPSCs Market Drivers
2.3.3 Human iPSCs Market Challenges
2.3.4 Human iPSCs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Human iPSCs by Players
3.1.1 Global Human iPSCs Revenue by Players (2018-2023)
3.1.2 Global Human iPSCs Revenue Market Share by Players (2018-2023)
3.2 Global Human iPSCs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Human iPSCs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Human iPSCs Market Concentration Ratio
3.4.1 Global Human iPSCs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human iPSCs Revenue in 2022
3.5 Global Key Players of Human iPSCs Head office and Area Served
3.6 Global Key Players of Human iPSCs, Product and Application
3.7 Global Key Players of Human iPSCs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HUMAN IPSCS BREAKDOWN DATA BY TYPE
4.1 Global Human iPSCs Historic Market Size by Type (2018-2023)
4.2 Global Human iPSCs Forecasted Market Size by Type (2024-2029)
5 HUMAN IPSCS BREAKDOWN DATA BY APPLICATION
5.1 Global Human iPSCs Historic Market Size by Application (2018-2023)
5.2 Global Human iPSCs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Human iPSCs Market Size (2018-2029)
6.2 North America Human iPSCs Market Size by Type
6.2.1 North America Human iPSCs Market Size by Type (2018-2023)
6.2.2 North America Human iPSCs Market Size by Type (2024-2029)
6.2.3 North America Human iPSCs Market Share by Type (2018-2029)
6.3 North America Human iPSCs Market Size by Application
6.3.1 North America Human iPSCs Market Size by Application (2018-2023)
6.3.2 North America Human iPSCs Market Size by Application (2024-2029)
6.3.3 North America Human iPSCs Market Share by Application (2018-2029)
6.4 North America Human iPSCs Market Size by Country
6.4.1 North America Human iPSCs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Human iPSCs Market Size by Country (2018-2023)
6.4.3 North America Human iPSCs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Human iPSCs Market Size (2018-2029)
7.2 Europe Human iPSCs Market Size by Type
7.2.1 Europe Human iPSCs Market Size by Type (2018-2023)
7.2.2 Europe Human iPSCs Market Size by Type (2024-2029)
7.2.3 Europe Human iPSCs Market Share by Type (2018-2029)
7.3 Europe Human iPSCs Market Size by Application
7.3.1 Europe Human iPSCs Market Size by Application (2018-2023)
7.3.2 Europe Human iPSCs Market Size by Application (2024-2029)
7.3.3 Europe Human iPSCs Market Share by Application (2018-2029)
7.4 Europe Human iPSCs Market Size by Country
7.4.1 Europe Human iPSCs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Human iPSCs Market Size by Country (2018-2023)
7.4.3 Europe Human iPSCs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Human iPSCs Market Size (2018-2029)
8.2 China Human iPSCs Market Size by Type
8.2.1 China Human iPSCs Market Size by Type (2018-2023)
8.2.2 China Human iPSCs Market Size by Type (2024-2029)
8.2.3 China Human iPSCs Market Share by Type (2018-2029)
8.3 China Human iPSCs Market Size by Application
8.3.1 China Human iPSCs Market Size by Application (2018-2023)
8.3.2 China Human iPSCs Market Size by Application (2024-2029)
8.3.3 China Human iPSCs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Human iPSCs Market Size (2018-2029)
9.2 Asia Human iPSCs Market Size by Type
9.2.1 Asia Human iPSCs Market Size by Type (2018-2023)
9.2.2 Asia Human iPSCs Market Size by Type (2024-2029)
9.2.3 Asia Human iPSCs Market Share by Type (2018-2029)
9.3 Asia Human iPSCs Market Size by Application
9.3.1 Asia Human iPSCs Market Size by Application (2018-2023)
9.3.2 Asia Human iPSCs Market Size by Application (2024-2029)
9.3.3 Asia Human iPSCs Market Share by Application (2018-2029)
9.4 Asia Human iPSCs Market Size by Region
9.4.1 Asia Human iPSCs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Human iPSCs Market Size by Region (2018-2023)
9.4.3 Asia Human iPSCs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Human iPSCs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Human iPSCs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Human iPSCs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Human iPSCs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Human iPSCs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Human iPSCs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Human iPSCs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Human iPSCs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Human iPSCs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Human iPSCs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Human iPSCs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Human iPSCs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Human iPSCs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Fujifilm Holding Corporation (CDI) Company Details
11.1.2 Fujifilm Holding Corporation (CDI) Business Overview
11.1.3 Fujifilm Holding Corporation (CDI) Human iPSCs Introduction
11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Human iPSCs Business (2018-2023)
11.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
11.2 Ncardia
11.2.1 Ncardia Company Details
11.2.2 Ncardia Business Overview
11.2.3 Ncardia Human iPSCs Introduction
11.2.4 Ncardia Revenue in Human iPSCs Business (2018-2023)
11.2.5 Ncardia Recent Developments
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Details
11.3.2 Sumitomo Dainippon Pharma Business Overview
11.3.3 Sumitomo Dainippon Pharma Human iPSCs Introduction
11.3.4 Sumitomo Dainippon Pharma Revenue in Human iPSCs Business (2018-2023)
11.3.5 Sumitomo Dainippon Pharma Recent Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Details
11.4.2 Astellas Pharma Inc Business Overview
11.4.3 Astellas Pharma Inc Human iPSCs Introduction
11.4.4 Astellas Pharma Inc Revenue in Human iPSCs Business (2018-2023)
11.4.5 Astellas Pharma Inc Recent Developments
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Details
11.5.2 Fate Therapeutics, Inc Business Overview
11.5.3 Fate Therapeutics, Inc Human iPSCs Introduction
11.5.4 Fate Therapeutics, Inc Revenue in Human iPSCs Business (2018-2023)
11.5.5 Fate Therapeutics, Inc Recent Developments
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Details
11.6.2 Pluricell Biotech Business Overview
11.6.3 Pluricell Biotech Human iPSCs Introduction
11.6.4 Pluricell Biotech Revenue in Human iPSCs Business (2018-2023)
11.6.5 Pluricell Biotech Recent Developments
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Details
11.7.2 Cell Inspire Biotechnology Business Overview
11.7.3 Cell Inspire Biotechnology Human iPSCs Introduction
11.7.4 Cell Inspire Biotechnology Revenue in Human iPSCs Business (2018-2023)
11.7.5 Cell Inspire Biotechnology Recent Developments
11.8 ReproCELL
11.8.1 ReproCELL Company Details
11.8.2 ReproCELL Business Overview
11.8.3 ReproCELL Human iPSCs Introduction
11.8.4 ReproCELL Revenue in Human iPSCs Business (2018-2023)
11.8.5 ReproCELL Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human iPSCs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Skin
1.2.3 Blood Cells
1.3 Market by Application
1.3.1 Global Human iPSCs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Human iPSCs Market Perspective (2018-2029)
2.2 Global Human iPSCs Growth Trends by Region
2.2.1 Human iPSCs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Human iPSCs Historic Market Size by Region (2018-2023)
2.2.3 Human iPSCs Forecasted Market Size by Region (2024-2029)
2.3 Human iPSCs Market Dynamics
2.3.1 Human iPSCs Industry Trends
2.3.2 Human iPSCs Market Drivers
2.3.3 Human iPSCs Market Challenges
2.3.4 Human iPSCs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Human iPSCs by Players
3.1.1 Global Human iPSCs Revenue by Players (2018-2023)
3.1.2 Global Human iPSCs Revenue Market Share by Players (2018-2023)
3.2 Global Human iPSCs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Human iPSCs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Human iPSCs Market Concentration Ratio
3.4.1 Global Human iPSCs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human iPSCs Revenue in 2022
3.5 Global Key Players of Human iPSCs Head office and Area Served
3.6 Global Key Players of Human iPSCs, Product and Application
3.7 Global Key Players of Human iPSCs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HUMAN IPSCS BREAKDOWN DATA BY TYPE
4.1 Global Human iPSCs Historic Market Size by Type (2018-2023)
4.2 Global Human iPSCs Forecasted Market Size by Type (2024-2029)
5 HUMAN IPSCS BREAKDOWN DATA BY APPLICATION
5.1 Global Human iPSCs Historic Market Size by Application (2018-2023)
5.2 Global Human iPSCs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Human iPSCs Market Size (2018-2029)
6.2 North America Human iPSCs Market Size by Type
6.2.1 North America Human iPSCs Market Size by Type (2018-2023)
6.2.2 North America Human iPSCs Market Size by Type (2024-2029)
6.2.3 North America Human iPSCs Market Share by Type (2018-2029)
6.3 North America Human iPSCs Market Size by Application
6.3.1 North America Human iPSCs Market Size by Application (2018-2023)
6.3.2 North America Human iPSCs Market Size by Application (2024-2029)
6.3.3 North America Human iPSCs Market Share by Application (2018-2029)
6.4 North America Human iPSCs Market Size by Country
6.4.1 North America Human iPSCs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Human iPSCs Market Size by Country (2018-2023)
6.4.3 North America Human iPSCs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Human iPSCs Market Size (2018-2029)
7.2 Europe Human iPSCs Market Size by Type
7.2.1 Europe Human iPSCs Market Size by Type (2018-2023)
7.2.2 Europe Human iPSCs Market Size by Type (2024-2029)
7.2.3 Europe Human iPSCs Market Share by Type (2018-2029)
7.3 Europe Human iPSCs Market Size by Application
7.3.1 Europe Human iPSCs Market Size by Application (2018-2023)
7.3.2 Europe Human iPSCs Market Size by Application (2024-2029)
7.3.3 Europe Human iPSCs Market Share by Application (2018-2029)
7.4 Europe Human iPSCs Market Size by Country
7.4.1 Europe Human iPSCs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Human iPSCs Market Size by Country (2018-2023)
7.4.3 Europe Human iPSCs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Human iPSCs Market Size (2018-2029)
8.2 China Human iPSCs Market Size by Type
8.2.1 China Human iPSCs Market Size by Type (2018-2023)
8.2.2 China Human iPSCs Market Size by Type (2024-2029)
8.2.3 China Human iPSCs Market Share by Type (2018-2029)
8.3 China Human iPSCs Market Size by Application
8.3.1 China Human iPSCs Market Size by Application (2018-2023)
8.3.2 China Human iPSCs Market Size by Application (2024-2029)
8.3.3 China Human iPSCs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Human iPSCs Market Size (2018-2029)
9.2 Asia Human iPSCs Market Size by Type
9.2.1 Asia Human iPSCs Market Size by Type (2018-2023)
9.2.2 Asia Human iPSCs Market Size by Type (2024-2029)
9.2.3 Asia Human iPSCs Market Share by Type (2018-2029)
9.3 Asia Human iPSCs Market Size by Application
9.3.1 Asia Human iPSCs Market Size by Application (2018-2023)
9.3.2 Asia Human iPSCs Market Size by Application (2024-2029)
9.3.3 Asia Human iPSCs Market Share by Application (2018-2029)
9.4 Asia Human iPSCs Market Size by Region
9.4.1 Asia Human iPSCs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Human iPSCs Market Size by Region (2018-2023)
9.4.3 Asia Human iPSCs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Human iPSCs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Human iPSCs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Human iPSCs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Human iPSCs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Human iPSCs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Human iPSCs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Human iPSCs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Human iPSCs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Human iPSCs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Human iPSCs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Human iPSCs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Human iPSCs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Human iPSCs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Fujifilm Holding Corporation (CDI) Company Details
11.1.2 Fujifilm Holding Corporation (CDI) Business Overview
11.1.3 Fujifilm Holding Corporation (CDI) Human iPSCs Introduction
11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Human iPSCs Business (2018-2023)
11.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
11.2 Ncardia
11.2.1 Ncardia Company Details
11.2.2 Ncardia Business Overview
11.2.3 Ncardia Human iPSCs Introduction
11.2.4 Ncardia Revenue in Human iPSCs Business (2018-2023)
11.2.5 Ncardia Recent Developments
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Details
11.3.2 Sumitomo Dainippon Pharma Business Overview
11.3.3 Sumitomo Dainippon Pharma Human iPSCs Introduction
11.3.4 Sumitomo Dainippon Pharma Revenue in Human iPSCs Business (2018-2023)
11.3.5 Sumitomo Dainippon Pharma Recent Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Details
11.4.2 Astellas Pharma Inc Business Overview
11.4.3 Astellas Pharma Inc Human iPSCs Introduction
11.4.4 Astellas Pharma Inc Revenue in Human iPSCs Business (2018-2023)
11.4.5 Astellas Pharma Inc Recent Developments
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Details
11.5.2 Fate Therapeutics, Inc Business Overview
11.5.3 Fate Therapeutics, Inc Human iPSCs Introduction
11.5.4 Fate Therapeutics, Inc Revenue in Human iPSCs Business (2018-2023)
11.5.5 Fate Therapeutics, Inc Recent Developments
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Details
11.6.2 Pluricell Biotech Business Overview
11.6.3 Pluricell Biotech Human iPSCs Introduction
11.6.4 Pluricell Biotech Revenue in Human iPSCs Business (2018-2023)
11.6.5 Pluricell Biotech Recent Developments
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Details
11.7.2 Cell Inspire Biotechnology Business Overview
11.7.3 Cell Inspire Biotechnology Human iPSCs Introduction
11.7.4 Cell Inspire Biotechnology Revenue in Human iPSCs Business (2018-2023)
11.7.5 Cell Inspire Biotechnology Recent Developments
11.8 ReproCELL
11.8.1 ReproCELL Company Details
11.8.2 ReproCELL Business Overview
11.8.3 ReproCELL Human iPSCs Introduction
11.8.4 ReproCELL Revenue in Human iPSCs Business (2018-2023)
11.8.5 ReproCELL Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Human iPSCs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Skin
Table 3. Key Players of Blood Cells
Table 4. Global Human iPSCs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Human iPSCs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Human iPSCs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Human iPSCs Market Share by Region (2018-2023)
Table 8. Global Human iPSCs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Human iPSCs Market Share by Region (2024-2029)
Table 10. Human iPSCs Market Trends
Table 11. Human iPSCs Market Drivers
Table 12. Human iPSCs Market Challenges
Table 13. Human iPSCs Market Restraints
Table 14. Global Human iPSCs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Human iPSCs Revenue Share by Players (2018-2023)
Table 16. Global Top Human iPSCs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPSCs as of 2022)
Table 17. Global Human iPSCs Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Human iPSCs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Human iPSCs, Headquarters and Area Served
Table 20. Global Key Players of Human iPSCs, Product and Application
Table 21. Global Key Players of Human iPSCs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Human iPSCs Revenue Market Share by Type (2018-2023)
Table 25. Global Human iPSCs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Human iPSCs Revenue Market Share by Type (2024-2029)
Table 27. Global Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Human iPSCs Revenue Share by Application (2018-2023)
Table 29. Global Human iPSCs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Human iPSCs Revenue Share by Application (2024-2029)
Table 31. North America Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Human iPSCs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Human iPSCs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Human iPSCs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Human iPSCs Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Human iPSCs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Human iPSCs Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Human iPSCs Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Human iPSCs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Human iPSCs Market Size by Country (2024-2029) & (US$ Million)
Table 63. Fujifilm Holding Corporation (CDI) Company Details
Table 64. Fujifilm Holding Corporation (CDI) Business Overview
Table 65. Fujifilm Holding Corporation (CDI) Human iPSCs Product
Table 66. Fujifilm Holding Corporation (CDI) Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 67. Fujifilm Holding Corporation (CDI) Recent Developments
Table 68. Ncardia Company Details
Table 69. Ncardia Business Overview
Table 70. Ncardia Human iPSCs Product
Table 71. Ncardia Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 72. Ncardia Recent Developments
Table 73. Sumitomo Dainippon Pharma Company Details
Table 74. Sumitomo Dainippon Pharma Business Overview
Table 75. Sumitomo Dainippon Pharma Human iPSCs Product
Table 76. Sumitomo Dainippon Pharma Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 77. Sumitomo Dainippon Pharma Recent Developments
Table 78. Astellas Pharma Inc Company Details
Table 79. Astellas Pharma Inc Business Overview
Table 80. Astellas Pharma Inc Human iPSCs Product
Table 81. Astellas Pharma Inc Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 82. Astellas Pharma Inc Recent Developments
Table 83. Fate Therapeutics, Inc Company Details
Table 84. Fate Therapeutics, Inc Business Overview
Table 85. Fate Therapeutics, Inc Human iPSCs Product
Table 86. Fate Therapeutics, Inc Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 87. Fate Therapeutics, Inc Recent Developments
Table 88. Pluricell Biotech Company Details
Table 89. Pluricell Biotech Business Overview
Table 90. Pluricell Biotech Human iPSCs Product
Table 91. Pluricell Biotech Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 92. Pluricell Biotech Recent Developments
Table 93. Cell Inspire Biotechnology Company Details
Table 94. Cell Inspire Biotechnology Business Overview
Table 95. Cell Inspire Biotechnology Human iPSCs Product
Table 96. Cell Inspire Biotechnology Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 97. Cell Inspire Biotechnology Recent Developments
Table 98. ReproCELL Company Details
Table 99. ReproCELL Business Overview
Table 100. ReproCELL Human iPSCs Product
Table 101. ReproCELL Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 102. ReproCELL Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 1. Global Human iPSCs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Skin
Table 3. Key Players of Blood Cells
Table 4. Global Human iPSCs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Human iPSCs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Human iPSCs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Human iPSCs Market Share by Region (2018-2023)
Table 8. Global Human iPSCs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Human iPSCs Market Share by Region (2024-2029)
Table 10. Human iPSCs Market Trends
Table 11. Human iPSCs Market Drivers
Table 12. Human iPSCs Market Challenges
Table 13. Human iPSCs Market Restraints
Table 14. Global Human iPSCs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Human iPSCs Revenue Share by Players (2018-2023)
Table 16. Global Top Human iPSCs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPSCs as of 2022)
Table 17. Global Human iPSCs Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Human iPSCs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Human iPSCs, Headquarters and Area Served
Table 20. Global Key Players of Human iPSCs, Product and Application
Table 21. Global Key Players of Human iPSCs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Human iPSCs Revenue Market Share by Type (2018-2023)
Table 25. Global Human iPSCs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Human iPSCs Revenue Market Share by Type (2024-2029)
Table 27. Global Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Human iPSCs Revenue Share by Application (2018-2023)
Table 29. Global Human iPSCs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Human iPSCs Revenue Share by Application (2024-2029)
Table 31. North America Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Human iPSCs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Human iPSCs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Human iPSCs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Human iPSCs Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Human iPSCs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Human iPSCs Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Human iPSCs Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Human iPSCs Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Human iPSCs Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Human iPSCs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Human iPSCs Market Size by Country (2024-2029) & (US$ Million)
Table 63. Fujifilm Holding Corporation (CDI) Company Details
Table 64. Fujifilm Holding Corporation (CDI) Business Overview
Table 65. Fujifilm Holding Corporation (CDI) Human iPSCs Product
Table 66. Fujifilm Holding Corporation (CDI) Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 67. Fujifilm Holding Corporation (CDI) Recent Developments
Table 68. Ncardia Company Details
Table 69. Ncardia Business Overview
Table 70. Ncardia Human iPSCs Product
Table 71. Ncardia Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 72. Ncardia Recent Developments
Table 73. Sumitomo Dainippon Pharma Company Details
Table 74. Sumitomo Dainippon Pharma Business Overview
Table 75. Sumitomo Dainippon Pharma Human iPSCs Product
Table 76. Sumitomo Dainippon Pharma Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 77. Sumitomo Dainippon Pharma Recent Developments
Table 78. Astellas Pharma Inc Company Details
Table 79. Astellas Pharma Inc Business Overview
Table 80. Astellas Pharma Inc Human iPSCs Product
Table 81. Astellas Pharma Inc Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 82. Astellas Pharma Inc Recent Developments
Table 83. Fate Therapeutics, Inc Company Details
Table 84. Fate Therapeutics, Inc Business Overview
Table 85. Fate Therapeutics, Inc Human iPSCs Product
Table 86. Fate Therapeutics, Inc Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 87. Fate Therapeutics, Inc Recent Developments
Table 88. Pluricell Biotech Company Details
Table 89. Pluricell Biotech Business Overview
Table 90. Pluricell Biotech Human iPSCs Product
Table 91. Pluricell Biotech Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 92. Pluricell Biotech Recent Developments
Table 93. Cell Inspire Biotechnology Company Details
Table 94. Cell Inspire Biotechnology Business Overview
Table 95. Cell Inspire Biotechnology Human iPSCs Product
Table 96. Cell Inspire Biotechnology Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 97. Cell Inspire Biotechnology Recent Developments
Table 98. ReproCELL Company Details
Table 99. ReproCELL Business Overview
Table 100. ReproCELL Human iPSCs Product
Table 101. ReproCELL Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 102. ReproCELL Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Human iPSCs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Human iPSCs Market Share by Type: 2022 VS 2029
Figure 3. Skin Features
Figure 4. Blood Cells Features
Figure 5. Global Human iPSCs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Human iPSCs Market Share by Application: 2022 VS 2029
Figure 7. Academic Research Case Studies
Figure 8. Drug Development and Discovery Case Studies
Figure 9. Toxicity Screening Case Studies
Figure 10. Regenerative Medicine Case Studies
Figure 11. Others Case Studies
Figure 12. Human iPSCs Report Years Considered
Figure 13. Global Human iPSCs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Human iPSCs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human iPSCs Market Share by Region: 2022 VS 2029
Figure 16. Global Human iPSCs Market Share by Players in 2022
Figure 17. Global Top Human iPSCs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPSCs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Human iPSCs Revenue in 2022
Figure 19. North America Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Human iPSCs Market Share by Type (2018-2029)
Figure 21. North America Human iPSCs Market Share by Application (2018-2029)
Figure 22. North America Human iPSCs Market Share by Country (2018-2029)
Figure 23. United States Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Human iPSCs Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Human iPSCs Market Share by Type (2018-2029)
Figure 27. Europe Human iPSCs Market Share by Application (2018-2029)
Figure 28. Europe Human iPSCs Market Share by Country (2018-2029)
Figure 29. Germany Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Human iPSCs Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Human iPSCs Market Share by Type (2018-2029)
Figure 37. China Human iPSCs Market Share by Application (2018-2029)
Figure 38. Asia Human iPSCs Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Human iPSCs Market Share by Type (2018-2029)
Figure 40. Asia Human iPSCs Market Share by Application (2018-2029)
Figure 41. Asia Human iPSCs Market Share by Region (2018-2029)
Figure 42. Japan Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Human iPSCs Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Human iPSCs Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Human iPSCs Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Human iPSCs Market Share by Country (2018-2029)
Figure 52. Brazil Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 59. Ncardia Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 60. Sumitomo Dainippon Pharma Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 61. Astellas Pharma Inc Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 62. Fate Therapeutics, Inc Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 63. Pluricell Biotech Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 64. Cell Inspire Biotechnology Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 65. ReproCELL Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Global Human iPSCs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Human iPSCs Market Share by Type: 2022 VS 2029
Figure 3. Skin Features
Figure 4. Blood Cells Features
Figure 5. Global Human iPSCs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Human iPSCs Market Share by Application: 2022 VS 2029
Figure 7. Academic Research Case Studies
Figure 8. Drug Development and Discovery Case Studies
Figure 9. Toxicity Screening Case Studies
Figure 10. Regenerative Medicine Case Studies
Figure 11. Others Case Studies
Figure 12. Human iPSCs Report Years Considered
Figure 13. Global Human iPSCs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Human iPSCs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human iPSCs Market Share by Region: 2022 VS 2029
Figure 16. Global Human iPSCs Market Share by Players in 2022
Figure 17. Global Top Human iPSCs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPSCs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Human iPSCs Revenue in 2022
Figure 19. North America Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Human iPSCs Market Share by Type (2018-2029)
Figure 21. North America Human iPSCs Market Share by Application (2018-2029)
Figure 22. North America Human iPSCs Market Share by Country (2018-2029)
Figure 23. United States Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Human iPSCs Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Human iPSCs Market Share by Type (2018-2029)
Figure 27. Europe Human iPSCs Market Share by Application (2018-2029)
Figure 28. Europe Human iPSCs Market Share by Country (2018-2029)
Figure 29. Germany Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Human iPSCs Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Human iPSCs Market Share by Type (2018-2029)
Figure 37. China Human iPSCs Market Share by Application (2018-2029)
Figure 38. Asia Human iPSCs Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Human iPSCs Market Share by Type (2018-2029)
Figure 40. Asia Human iPSCs Market Share by Application (2018-2029)
Figure 41. Asia Human iPSCs Market Share by Region (2018-2029)
Figure 42. Japan Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Human iPSCs Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Human iPSCs Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Human iPSCs Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Human iPSCs Market Share by Country (2018-2029)
Figure 52. Brazil Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Human iPSCs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 59. Ncardia Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 60. Sumitomo Dainippon Pharma Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 61. Astellas Pharma Inc Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 62. Fate Therapeutics, Inc Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 63. Pluricell Biotech Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 64. Cell Inspire Biotechnology Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 65. ReproCELL Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
